Portal Hypertension Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Single User License $3500

Portal Hypertension Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Status : October, 2020 | Pharmaceutical | PPT format

Report Digest


Global Portal Hypertension Market: Snapshot

At present, treatment options for portal hypertension is limited due to the dearth of approval of specialized drugs. The generic drugs hold a sway over the market and the scope of treatment under them include beta blockers, vasopressin and its analogues, and somatostatin and its analogues. In the near future, the portal hypertension market is primed to grow at a healthy clip due to the spike in liver cirrhosis, which may cause portal hypertension and other hepatic disorders.   

Portal hypertension results in increase of blood pressure within the portal venous system. It may cause veins in stomach, esophagus, umbilical area, or rectum to swell. In extreme cases, these swollen vein can rupture and bleed, thereby causing life-threatening complications. 

Some of the noteworthy candidates under phase III of clinical trials are Udenafil (DA-8519), Sapropterin (tetrahydrobiopterin), and Octreolin (octreotide). When approved and launched, these drugs would have the potential to rake in substantial revenue in the market. 

As far as diagnosis is concerned, Duplex Doppler ultrasonography has been seeing robust demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as angioplasty, computed tomography (CT) scanning, bleeding scan, and magnetic resonance imaging (MRI) are also considered aviable methods for precise diagnosis.

Noteworthy names operating in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., Dong-A Socio Holdings Co Ltd., Novartis AG, United Therapeutics Corporation, Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Chiasma, Inc., Govind Ballabh Pant Hospital, and Dr. Falk Pharma GmbH.

Global Portal Hypertension Market: Overview 

Portal hypertension is a clinical condition in which blood pressure within the portal venous system increases. The condition may lead to the development of swollen veins within stomach, esophagus, umbilical area, or rectum. In severe cases, these swollen vein can rupture and bleed, thereby leading to potentially life-threatening complications. As per reports, liver cirrhosis is the most common cause of portal hypertension. Hence a rising incidence of liver cirrhosis is often related to the increasing demand for effective treatment for portal hypertension. 

In this report, TMR Research not only evaluates opportunities prevalent for the available treatment and diagnosis techniques for portal hypertension but also presents a detailed assessment of therapeutic pipeline. The potential market trajectory post approval of novel therapeutics is determined based on exhaustive information obtained from proven industrial sources. The report thus compiles data aimed at providing a comprehensive overview of the global portal hypertension market to the readers. 

Global Portal Hypertension Market: Available Treatment Options 

Duplex Doppler ultrasonography has been witnessing significantly high demand on being the current available imaging technique applied for diagnosing portal hypertension. Besides this, methods such as a computed tomography (CT) scanning, bleeding scan, angioplasty, and magnetic resonance imaging (MRI) are also considered viable methods for precise diagnosis.  As these constitute key segments in the global hypertension market, the report presents an in-depth analysis of the factors influencing the market’s trajectory across aforementioned segments. 

The currently available treatment for portal hypertension includes medications comprising beta blockers such as Propranolol and Nadolol and endoscopic therapies such as sclerotherapy and banding. Vasoactive agents are also preferred in the treatment of portal hypertension due to its ability of reducing the in-variceal bleeding and ultimately helping to lower the blood pressure. In acute conditions vasoconstrictors such as octreotide and somastostatin are administered, which explains their high demand in the global portal hypertension market. 

Global Portal Hypertension Market: Therapeutics and Pipeline Analysis 

The global market for portal hypertension currently has a limited number of treatment options and there is absence of a specialized drugs approved to be administered for the treatment of portal hypertension. However, the generic drugs segment currently holds dominance in the market, the scope of treatment under which includes vasopressin and its analogues, beta blockers, and somatostatin and its analogues. This also demonstrates lucrative prospects for therapeutic research and development. As per TMR, the portal hypertension market is poised to exhibit exponential growth on account of the increasing incidence of liver cirrhosis, which may lead to portal hypertension and other hepatic disorders.   

The pipeline analysis of the market consists of products currently under the phase III of clinical trials. Some of the most notable candidates are Sapropterin (tetrahydrobiopterin), Octreolin (octreotide), and Udenafil (DA-8519). Once approved, the launch of these drugs could generate high revenue for the market. 

Global Portal Hypertension Market: Vendor Landscape 

To study the competition prevailing in the global portal hypertension market, the report profiles a few of the companies operating therein. It conducts SWOT analysis to evaluate the strengths and weaknesses of the companies profiled and identify threats and opportunities that these enterprises could face over the course of the forecast period. Some of the prominent players in the global portal hypertension market are Ono Pharmaceutical Co., Ltd., United Therapeutics Corporation, Chiasma, Inc., Genextra S.p.a., Aptalis Pharma Inc., Gilead Sciences, Inc., Debiovision, Inc., Dong-A Socio Holdings Co Ltd., Govind Ballabh Pant Hospital, Dr. Falk Pharma GmbH, and Novartis AG.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?